Detalhe da pesquisa
1.
Development of a platform process for the production and purification of single-domain antibodies.
Biotechnol Bioeng
; 118(9): 3348-3358, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624832
2.
Fibulin-2 is a key mediator of the pro-neurogenic effect of TGF-beta1 on adult neural stem cells.
Mol Cell Neurosci
; 67: 75-83, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26051800
3.
Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells.
Proc Natl Acad Sci U S A
; 109(20): 7835-40, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547816
4.
Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
BMC Vet Res
; 10: 8, 2014 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24401205
5.
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.
Toxicol Appl Pharmacol
; 268(3): 318-30, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23403069
6.
Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells.
Mol Ther
; 20(4): 808-19, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22233583
7.
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.
Proc Natl Acad Sci U S A
; 107(46): 20021-6, 2010 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21030678
8.
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics.
J Virol
; 84(12): 6007-17, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20375153
9.
Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia.
Mol Pain
; 5: 42, 2009 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19656360
10.
High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity.
J Virol
; 82(9): 4680-4, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287240
11.
Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.
Mol Ther
; 16(2): 343-51, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18180781
12.
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model.
Neuro Oncol
; 10(1): 19-31, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18079358
13.
Regulated expression of adenoviral vectors-based gene therapies: therapeutic expression of toxins and immune-modulators.
Methods Mol Biol
; 434: 239-66, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18470649
14.
Iron Availability Compromises Not Only Oligodendrocytes But Also Astrocytes and Microglial Cells.
Mol Neurobiol
; 55(2): 1068-1081, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28092084
15.
Chronic Hippocampal Expression of Notch Intracellular Domain Induces Vascular Thickening, Reduces Glucose Availability, and Exacerbates Spatial Memory Deficits in a Rat Model of Early Alzheimer.
Mol Neurobiol
; 55(11): 8637-8650, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582397
16.
Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Neuro Oncol
; 9(3): 245-58, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17522335
17.
Combined immunostimulation and conditional cytotoxic gene therapy provide long-term survival in a large glioma model.
Cancer Res
; 65(16): 7194-204, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16103070
18.
Gene therapy for pituitary tumors.
Curr Gene Ther
; 5(6): 559-72, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16457646
19.
Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.
Clin Cancer Res
; 20(6): 1555-1565, 2014 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24501391
20.
Interleukin-1ß and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?
Front Cell Neurosci
; 7: 53, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23641196